Advertisement

Der viscerale Lupus erythematosus (Kaposi-Libman-Sacks-Syndrom)

  • W. Siegenthaler
  • R. Hegglin
Conference paper
Part of the Ergebnisse der Inneren Medizin und Kinderheilkunde book series (KINDERHEILK. NF, volume 7)

Zusammenfassung

In den letzten Jahren hat die von Cazenave (48) im Jahre 1851 als Lupus érythémateux bezeichnete Hautkrankheit aus verschiedenen Gründen eine besondere Bedeutung erlangt. Die Krankheit war unter anderen Namen schon früher bekannt und ist nach Cohen und Cadman (55) bereits 1817 von Bateman (18) als Ichthyosis faciei, 1927 von Rayer (259) als Flux cébacé, 1828 von Biett (21) als Erythème centrifuge, 1841 von Willis (331) als Hypertrophia folliculorum, 1845 von Erichsen (86) als Acne cébacé, ebenfalls 1845 von Hebra (139,140) als Seborrhoea congestiva, 1847 von Wilson (332) als Inflammatio folliculorum und 1850 von Parkes (249) als Lupus superficialis erwähnt worden. Mit der von Cazenave (48) gewählten Bezeichnung, die sich in der Folge auch allgemein eingebürgert hat, sollte vor allem die morphologische Ähnlichkeit zum Lupus vulgaris zum Ausdruck kommen. Diese gab denn auch die Veranlassung immer wieder die tuberkulöse Ätiologie zu diskutieren, die erst viel später in ablehnendem Sinne beantwortet wurde.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Aegerter, E., and J. H. Long: The collagen diseases. Amer. J. Med. Sci.218, 324 (1949).CrossRefGoogle Scholar
  2. 2.
    Albertini, A. v.: Zum Problem der Endokarditis. Schweiz, med. Wschr. 1935, 200Google Scholar
  3. 3.
    Albertini, A. v. u. O. Alb: Über die atypische verrucose Endocarditis Libman-Sacks und ihre Beziehungen zum Lupus erythematodes acutus. Cardiologia (Basel) 12, 133 (1947).Google Scholar
  4. 4.
    Altshuler, C. H., and D. M. Angevine: Histochemical studies on the pathogenesis of fibrinoid. Amer. J. Path. 25, 1061 (1949).PubMedGoogle Scholar
  5. 5.
    Aronofp, a., E. G. L. Bywaters and G. R. Fearnley: Lung lesions in rheumatoid arthritis. Brit. Med. J. 1955 II, 228.Google Scholar
  6. 6.
    Arnold, H. L.: Systemic lupus erythematosus. Arch, of Dermat. 62, 632 (1950).CrossRefGoogle Scholar
  7. 7.
    Baehr, G.: Renal complications of endocarditis. Trans. Assoc. Amer. Physicians 46, 87 (1931).Google Scholar
  8. 8.
    Baehr, G. P. Klemperer and A. Schifrin: Diffuse diseases of the peripheral circulation (usuahy associated with lupus erythematosus and endocarditis). Trans. Assoc. Amer. Physicians 50, 139 (1935).Google Scholar
  9. 9.
    Baehr, G. P. Klemperer and A. Schifrin and A. D. Pollack: Disseminated lupus erythematosus and diffuse scleroderma. J. Amer. Med. Assoc. 134, 1169 (1947).CrossRefGoogle Scholar
  10. 10.
    Baggenstoss, a. H.: Visceral lesions in disseminated lupus erythematosus. Proc. Staff Meet. Mayo Chn. 27, 412 (1952.Google Scholar
  11. 11.
    Ball, J. D., A. W. Williams and J. N. P. Davies: Endomyocardial fibrosis. Lancet 1954, 1049.Google Scholar
  12. 12.
    Barnes, S. S., T. W. Moffatt, C. W. Lane and R. S. Weiss: Studies on the L. E. phenomenon. Arch, of Dermat. 62, 771 (1950).CrossRefGoogle Scholar
  13. 13.
    Barnes, S. S., T. W. Moffatt, C. W. Lane and R. S. Weiss: Demonstration of the L. E. ceh in the absence of anticoagulant. J. Invest. Dermat. 14, 397 (1950).Google Scholar
  14. 14.
    Barnes, S. S., T. W. Moffatt, C. W. Lane and R. S. Weiss Studies on the L. E. phenomenon (Evolution of the induced L. E. inclusion body). J. Invest. Dermat. 15, 403 (1950).CrossRefGoogle Scholar
  15. 15.
    Barondess, J. A.: Thrombotic thrombocytopenic purpura. Review of the literature and report of three cases. Amer. J. Med. 13, 294 (1952).PubMedCrossRefGoogle Scholar
  16. 16.
    Barr, D. P., G. C. Reader and C. H. Wheeler: Cyroglobulinemia. I. Report of two cases with discussion of chnical manifestations, incidence and significance. Ann. Int. Med. 32, 6 (1949).Google Scholar
  17. 17.
    Basset-Lacronique, P.: Signes biologiques du L. E. D. Semaine Hôp. 1955, 349.Google Scholar
  18. 18.
    Bateman, t.: Declinations of cutaneous diseases, London 1817; zit. nach Cohen u. Cabman.Google Scholar
  19. 19.
    Bauer, K.: Disseminated lupus erythematosus with Sydenham’s chorea and rheumatic heart disease. Ann. Int. Med. 33, 1042 (1950).PubMedGoogle Scholar
  20. 20.
    Becker, B. J. P., C. B. Chatgidakis and B. van Lingen: Cardiovascular cohagenosis with parietal endocardial thrombosis. A chnico-pathologic study of forty cases. Circulation (New York) 7, 345 (1953).Google Scholar
  21. 21.
    Beerman, H.: The L. E. cell and phenomenon in lupus erythematosus. Amer. J. Med. Sci. 222, 473 (1951).PubMedCrossRefGoogle Scholar
  22. 22.
    Beerman, H. I. L. Schamberg, L. Nicholas and L. Katzenstein: Syphilis. Review of the recent hterature. Lupus erythematosus and false-positive serologic tests for syphihs. Arch. Int. Med. 93, 592 (1954).Google Scholar
  23. 23.
    Beigelman, P. M.: Variants of the platelet thrombosis syndrome and their relationship to disseminated lupus. Arch, of Path. 51, 213 (1951).Google Scholar
  24. 24.
    Belote, G.: Lupus erythematosus disseminatus: its present status. Arch, of Dermat. 39, 793 (1939).CrossRefGoogle Scholar
  25. 25.
    Belote, G.and. Ratner: The so-called Libman-Sacks syndrom: its relation to dermatology. Arch, of Dermat. 33, 642 (1936).CrossRefGoogle Scholar
  26. 26.
    Berman, L., A. R. Axelord, H. L. Goodman and R. I. Mlaughry: So-called “lupus erythematosus inclusion phenomenon” of bone marrow and blood. Amer. J. Clin. Path. 20, 403 (1950).Google Scholar
  27. 27.
    26a. Bickel, G.: Les manifestations cliniques des maladies du collagene. Méd. Hyg. 13, 484 (1955).Google Scholar
  28. 28.
    Biett, T.: Zit. nach Cazenave u. Schedel.Google Scholar
  29. 29.
    Bille, B. S.V.: Lupus erythematosus disseminatus with and without skin eruption. Acta med. scand. (Stockh.) 140, 280 (1951).CrossRefGoogle Scholar
  30. 30.
    Boas, N. P., and M. Reiner: Effect of ACTH and Cortisone on Serum hexosamine and gamma-globulin levels in acute disseminated lupus erythematosus. J. Clin. Endocrin. 11, 890 (1951).CrossRefGoogle Scholar
  31. 31.
    Bolgert, M., M. Le Sourd et J. Gariage: Lupus érythémateux exanthématique guéri depuis deux ans et demi. VIII. Congrès des Dermatologistes et Syphihgraphes de langue française, 1953, Communications, G. Thomas, Nancy.Google Scholar
  32. 32.
    Bolgert, M., M. Le Sourd et J. Gariage et M. Le Sourd: A propos du pronostic éloigné du lupus erythémateux aigu. VIII. Congrès des Dermatologistes et Syphihgraphes de langue française, 1953. Communications, G. Thomas, Nancy.Google Scholar
  33. 33.
    Bollet, a. J., and J. J. Bunim: Treatment of systemic lupus erythematosus with Prednisone and Prednisolone. J. Amer. Med. Assoc. 159, 1501 (1955).CrossRefGoogle Scholar
  34. 34.
    Brenner, J. J., W. A. Leff and E. Hochstein: Lupus erythematosus disseminatus sine lupo with the nephrotic syndrome. Amer. J. Med. 5, 288 (1948).PubMedCrossRefGoogle Scholar
  35. 35.
    Bridge, B. G., and P. E. Foley: Placental transmission of the lupus erythematosus factor. Amer. J. Med. Sci. 227, 1 (1954).PubMedCrossRefGoogle Scholar
  36. 36.
    Brunsting, L. a., C. H. Slocumb and J. W. Didcot: Effects of Cortisone on acute disseminated lupus erythematosus. Arch, of Dermat. 63, 29 (1951).CrossRefGoogle Scholar
  37. 37.
    34a. Brüx, J. de: Constitution histochemique de la substance fondamentale et maladies dites du collagène. Presse méd. 1951, 627.Google Scholar
  38. 38.
    Büchler, H.: Syndrom von Libman und Sacks. Praxis (Bern) 36, 202 (1947).Google Scholar
  39. 39.
    Buckley, S.: Atypische verruköse Endocarditis mit Haut-und vasculären Erscheinungen (Libman-sackssches Syndrom) bei einem 10 jährigen Mädchen. Helvet. paediatr. Acta 1, 542 (1946).Google Scholar
  40. 40.
    Bundick, W. R., and F. A. Ellis: Lupus erythematosus. Classification, diagnostic and prognostic value of biopsies. South. Med. J. 44, 204 (1951).PubMedCrossRefGoogle Scholar
  41. 41.
    Burckhardt, W., U.M.Kartagener: Libman-Sacks-Syndrom durch Penicillin günstig beemflußt. Dermatologica (Basel) 100, 320 (1950).CrossRefGoogle Scholar
  42. 42.
    Burckhardt, W., U.M.Kartagener Atlas und Praktikum der Dermatologie und Venerologie. München und Berlin: Urban und Schwarzenberg 1955.Google Scholar
  43. 43.
    Bureau, Y., P. Jarry et J. Barrière: Action de l’ACTH dans plusieurs cas de lupus érythémateux exanthématique. VIII. Congrès des Dermatologistes et Syphihgraphes de langue française, 1953. Communications, G. Thomas, Nancy.Google Scholar
  44. 44.
    Bürens, A., et M. Bolgert: Remarques sur l’histochimie du lupus érythémateux. VIII. Congrès des Dermatologistes et Syphihgraphes de langue française, 1953. Communications, G. Thomas, Nancy.Google Scholar
  45. 45.
    Buser, M.: Vergleichende Untersuchungen über das Still- und Felty-Syndrom. (Anhand eines Faües von Still-Syndrom mit atypischer verrucöser Endocarditis Lib- man-Sacks). Dtsch. med. Wschr. 1950, 819.Google Scholar
  46. 46.
    Buser, M.: Vergleichende Untersuchungen über das Still- und Felty-Syndrom anhand eines Falles von Still-Syndrom mit atypischer verruköser Endocarditis Libman-Sacks. Inaugural-Dissertation, Zürich 1948.Google Scholar
  47. 47.
    Butterworth, C. E.: The production of L. E. ceüs in normal individuals. J. Clin. Invest. 32, 558 (1953).Google Scholar
  48. 48.
    Capelli, E.: Basi teoriche e reahzzazione sperimentale « in vitro » del « fenomeno del lupus eritematose» nel sangue di individui normali mediante un siero antireticolo-endotelio umano. L’erytematodes malattia da autoanticorpi? Minerva dermat. (Torino) 27, Nr. 10 (1952).Google Scholar
  49. 49.
    Capelli, E. Erytematodes e malattie da auto-aggressione. Minerva dermat. (Torino) 28. Nr. 12 (1953).Google Scholar
  50. 50.
    Caplan, a.: Thorax 8, 29 (1953); zit. nach Aronoef u. Mitarb.Google Scholar
  51. 51.
    Carrera, A. E., M. V. Reid and N. B. Kurnick: Differences of suscepitbility of polymorphonuclear leukocytes from several species to alteration by systemic lupus erythematosus serum: apphcation to a more sensitive L.E.-Phenomenon-test. Blood 9, 1165 (1954).PubMedGoogle Scholar
  52. 52.
    Cazenave, A.: Conférence sur le lupus érythémateux. Ann. des malad, de la peau et de la syphüis, 3, 297 (1851).Google Scholar
  53. 53.
    Cazenave, A. et H. E. Schedel: Abrégé pratique des maladies de la peau, p. 386. Paris 1828.Google Scholar
  54. 54.
    Chomet, B., M. M. Kirshen, G. Schaefer and P. Mudrik: The finding of the L. E. (Lupus erythematosus) ceüs in smears of untreated, freshly drawn peripheral blood. Blood 18, 1107 (1953).Google Scholar
  55. 55.
    Christian, H.A.: Long-continued fever with inflammatory changes in serous and sjmovial membranes and eventual glomerulonephritis: a chnical syndrome of unknown etiology. Med. Clin. N. Amer. 18, 1023 (1935).Google Scholar
  56. 56.
    Clark, E. C., and A. A. Bailey: Neurological and psychiatric signs associated with systemic lupus erythematosus. J. Amer. Med. Assoc. 160, 455 (1956).CrossRefGoogle Scholar
  57. 57.
    Clough, P. W.: Cagen diseases. Ann. Int. Med. 42, 209 (1955).PubMedGoogle Scholar
  58. 58.
    Cluxton, H. E., and L. A. Krause: Acute lupus erythematosus disseminatus. Arch. Int. Med. 71, 843 (1943).Google Scholar
  59. 59.
    Coburn, A. F., and D. H. Moore: The plasma proteins in disseminated lupus erythematosus. Bull. Johns Hopkms Hosp. 73, 196 (1943).Google Scholar
  60. 60.
    Cohen, H., and E. F. B. Cadman: The natural history of lupus erythematosus and its modification by Cortisone and Corticotrophin (ACTH). Lancet 1953, 305.Google Scholar
  61. 61.
    Comens, Ph., and H. A. Schroeder: The L. E. c as a manifestation of delayed Hydralazine intoxication. J. Amer. Med. Assoc. 160, 1134 (1956).CrossRefGoogle Scholar
  62. 62.
    Conley, C. L., and R. C. Hartmann: A hemorrhagic disorder caused by circulating anticoagulant in patients with disseminated lupus erythematosus. J. Chn. Invest. 31, 621 (1952).Google Scholar
  63. 63.
    Coste, F., et B. Piguet: Lupus érythémateux subaigu disséminé à forme articulaire. Buü. Soc. méd. Hôp. Paris 69, 132 (1953).Google Scholar
  64. 64.
    Coste, F., et B. Piguet F. Lacronique et J. Françon: Lupus érythémateux disséminés aigus à forme polyarthritique confirmés par la présence de cules de Hargraves. B. Soc. méd. Hôp. Paris 70, 177 (1954).Google Scholar
  65. 65.
    Coste, F., et B. Piguet F. Lacronique et J. Françon J. Turiaf, et P. Blanchon: Lupus érythémateux disséminé à forme polyarthritique. B. Soc. méd. Hôp. Paris 69, 143 (1953).Google Scholar
  66. 66.
    Daly, D.: Central nervous system in acute disseminated lupus erythematosus. J. Nerv. Ment. Dis. 102, 461 (1945).PubMedCrossRefGoogle Scholar
  67. 67.
    Dameshek, W., and M.L.Bloom: Bone marrow examinations and the L.E. ceh. Blood 5, 101 (1950).Google Scholar
  68. 68.
    Danopoulos, E., u. K. Melissinos: Ausgedehnte Ejiochenveränderungen bei einer an Lupus erythematosus disseminatus leidenden Patientin. Wien.Z. inn. Med. 35,198 (1954).PubMedGoogle Scholar
  69. 69.
    Daugherty, G. W., and A. H. Baggenstoss: S;pidrome characterized by glomerulonephritis and arthritis. Libman-Sacks disease with predominantly renal involvement. Arch. Int. Med. 85, 900 (1950).CrossRefGoogle Scholar
  70. 70.
    Dahsset, J.: Immuno-hématologie et maladies d’auto-aggression. Schweiz, med. Wschr. 1953, 1037.Google Scholar
  71. 71.
    63b. Davies, B. M.: Disseminated lupus erythematosus, with renal involvement, treated with Nitrogen-Mustard. Brit. Med. J. 1956 I, 670.CrossRefGoogle Scholar
  72. 72.
    Degos, R.: Piokilodermatomyosite évoluant en un an vers la mort. Fait de passage avec le lupus érythémateux aigu et le syndrome de Libman-Sacks. Bull. Soc. franç. Dermat. 52, 189 (1945).Google Scholar
  73. 73.
    Delacrétaz, J., Th. Inderbitzin et P. Miescher: Les phénomènes pseudo-L. E. Schweiz, med. Wschr. 1954, 1103.Google Scholar
  74. 74.
    Denzer, b. s., and s. Blumenthal: Acute lupus erythematosus disseminatus. Amer. J. Dis. Childr. 53, 525 (1937).Google Scholar
  75. 75.
    Dietrich, A.: Allgemeine Pathologie. Leipzig: Hirzel 1939.Google Scholar
  76. 76.
    Dittrich, h., u. e. Frühmann: Untersuchungen zum Mechanismus der Lupus ery- thematodes-Zellbildung. Hautarzt 5, 217 (1952).Google Scholar
  77. 77.
    Dittrich, H., u. E. Frühmann: Untersuchungen zum Problem der experimentehen Bildung von L.E.-Zellen. Acta haemat. 10, 239 (1953).PubMedCrossRefGoogle Scholar
  78. 78.
    Dowling, G. B.: Lupus erythematosus. Practitioner 173, 140 (1954).PubMedGoogle Scholar
  79. 79.
    Dubois, E. L.: Acquired hemolytic anemia as the presenting syndrome in lupus erythematosus. Amer. J. Med. 12, 197 (1952).PubMedCrossRefGoogle Scholar
  80. 80.
    Dubois, E. L.: Simphfied method for the L. E. cell test. Results of a three-year study of seven hundred tests in many disease states. Arch. Int. Med. 92, 168 (1953).Google Scholar
  81. 81.
    Dubois, E. L. The effect of the L. E. ceh test on the clinical picture of systemic lupus erythematosus. Ann. Int. Med. 38, 1265 (1953).Google Scholar
  82. 82.
    Dubois, E. L. Systemic lupus erythematosus. California Med. 80, 154 (1954).PubMedGoogle Scholar
  83. 83.
    Dubois, E. L. Nitrogen mustard in treatment of systemic lupus erythematosus. Arch. Int. Med. 93, 667 (1954).CrossRefGoogle Scholar
  84. 84.
    Dubois, E. L. Quinacrine (Atebrine) in treatment of systemic and discoid lupus ervthematosus. Arch. Int. Med. 94, 131 (1954).CrossRefGoogle Scholar
  85. 85.
    Dubois, E. L. R. R. Commons, P. Starr, C. S. Stein u. R. Morrison: Corticotropin and Cortisone treatment for systemic lupus erythematosus. J. Amer. Med. Assoc. 149, 995 (1952).CrossRefGoogle Scholar
  86. 86.
    Dubois, E. L., and St. Martel: Discoid lupus erythematosus: an analysis of its systemic manifestations. Ann. Int. Med. 44, 482 (1956).PubMedGoogle Scholar
  87. 87.
    Duperrat, B.: Particularités sémiologiques d’un cas de lupus érythémateux disséminé. VIII. Congrès des Dermatologistes et Syphihgraphes de langue française, 1953. Communications, G. Thomas, Nancy.Google Scholar
  88. 88.
    Duverne, j., r. Bonnaymé, j. Alligier et r. Mounier: Lupus érythémateux aigu succédant à un lupus érythémateux chronique, déclenché par le Bismuth et avec fausses réactions sérologiques. VIII. Congrès des Dermatologistes et Syphihgraphes de langue française, 1953. Communications, G. Thomas, Nancy.Google Scholar
  89. 89.
    Dustan, H. P., R. D. Taylor, A. C. Corcoran and I. H. Page: Rheumatic and febrile Syndrome during prolonged Hydralazine treatment. J. Amer. Med. Assoc. 154, 23 (1954).CrossRefGoogle Scholar
  90. 90.
    Editorial: Der akute und subakute, äußere und innere Erythematodes und die dabei vorkommenden Zeh- und serologischen Phänomene. Dtsch. med. Wschr. 1951, 1538.Google Scholar
  91. 91.
    Dustan, H. P., R. D. Taylor, A. C. Corcoran and I. H. Page Disseminated lupus erythematosus. Brit. Med. J. 1954 II, 798.Google Scholar
  92. 92.
    Edlbacher, S., u. P. Leuthard: Lehrbuch der physiologischen Chemie. Berlin: Walter de Gruyter & Co. 1954.Google Scholar
  93. 93.
    Ehrich, W. E.: Nature of cohagen diseases. Amer. Heart J. 43, 12 (1952).CrossRefGoogle Scholar
  94. 94.
    Ellis, R. A., and E. S. Bereston: Lupus erythematosus associated with pregnancy and menopause. Arch, of Dermat. 65, 170 (1952).CrossRefGoogle Scholar
  95. 95.
    Ellis, F. A., and W. R. Bundick: Histology of lupus erythematosus. Arch, of Dermat. 70, 711 (1954).Google Scholar
  96. 96.
    Eppes, W., and E. Ludovic: Demonstration of the L.E. cell without use of anticoagulants. Blood 6, 466 (1951).Google Scholar
  97. 97.
    Erichsen, J.: London Med. Gaz. 36, 1235 (1845); zit. nach Cohen u. Cadman.Google Scholar
  98. 98.
    Fallet, G. H., J. Spahr, A. Mégevand, G. Roth, H. Castella et H. Golschmid: Le lupus érythémateux disséminé (Lupo-érythémato-viscérite maligne) et son diagnostic hématologie. Etude de six observations. Semaine Hôp. 1955, 337.Google Scholar
  99. 99.
    Ferrari, A. V.: Sur trois cas de lupus érythémateux aigu. Vili. Congrès des Dermatologistes et Syphihgraphes de langue française, 1953. Communications, G. Thomas, Nancy.Google Scholar
  100. 100.
    Fisher, G. S., and J. E. Moyer: Hematologic phenomena as a test for acute disseminated lupus erythematosus. Grace Hosp. Bull. (Detroit) 28, 3 (1950).Google Scholar
  101. 101.
    Foldes, J.: Acute systemic lupus erythematosus. Amer. J. Clin. Path. 16, 160 (1946).Google Scholar
  102. 102.
    90a. Fornara, P., M. Genesi: Il lupus eritematoso acuto disseminato nell infanzia. Minerva pediatr. 7, Nr. 9 (1955).Google Scholar
  103. 103.
    Forster, R., u. E. Uehlinger: Zur Kenntnis des Libman-Sacksschen Syndroms. Helvet. med. Acta 14, 368 (1947).PubMedGoogle Scholar
  104. 104.
    Fox, R. A.: Disseminated lupus erythematosus — an allergie disease? Arch, of Path. 36, 311 (1943).Google Scholar
  105. 105.
    Fox, R. A. and P. D. Ros ahn: The lymph nodes in disseminated lupus erythematosus. Amer. J. Path. 19, 73 (1943).PubMedGoogle Scholar
  106. 106.
    93a. Frank, H.: Khnische Beobachtungen beim disseminierten Lupus erythematodes. Ärztl. Wschr. 1956, 127.Google Scholar
  107. 107.
    Franke, H., u. H. Wördehoff: Zur Diagnose und Therapie der sog. Libman-Sacks- schen Erkrankung. Z. klin. Med. 148, 396 (1951).Google Scholar
  108. 108.
    94a. Frauchiger, E.: Persönliche Mitteilung.Google Scholar
  109. 109.
    Frick, P. G.: Acquired circulating anticoagulants in systemic “collagen disease”. Autoimmune thromboplastin deficiency. Blood 10, 691 (1955).PubMedGoogle Scholar
  110. 110.
    Fricsay, M.: Die pulmonale Form des Lupus erythematosus disseminatus acutus. Schweiz, med. Wschr. 1956, 269.Google Scholar
  111. 111.
    Friedberg, Ch., L. Gross and K.Wallach: Non bacterial thrombotic endocarditis associated with prolonged fever, arthritis, inflammation of serous membranes and widespread vascular lesions. Arch. Int. Med. 58, 662 (1936).CrossRefGoogle Scholar
  112. 112.
    Friedmann, E., et G. Pathé: A propos du traitement du lupus érythémagteux aigu par l’ACTH (un cas traité depuis 32 mois). VIII. Congrès des Dermatologistes et Syphihgraphes de langue française, 1953. Communications, G. Thomas, Nancy.Google Scholar
  113. 113.
    Friedman, H. H., S. Schwartz, M. Trubek and O. Steinbrocker: The “para-rheumatic” arthropathies. Ann. Int. Med. 38, 732 (1953).PubMedGoogle Scholar
  114. 114.
    Gaté, J., et P. Morel: Particularités cytologiques dans un cas de lupo-érythémato- viscérite. Vili. Congrès des Dermatologistes et Syphihgraphes de langue française, 1953. Communications, G. Thomas. Nancy.Google Scholar
  115. 115.
    Gay Prieto, J.: Etiologie, pathogénie et traitement du lupus érythémateux. VIII. Congrès des Dermatologistes et Syphihgraphes de langue française. 1953. Rapports, H. Thomas, Nancy, p. 68.Google Scholar
  116. 116.
    102a. Geddings, H.: Zit. nach Kaposi.Google Scholar
  117. 117.
    102b. Geiser, P.: Zur Klinik und Therapie der Capillaritis generalisata maligna. Helvet. med. Acta 14, 382 (1947).Google Scholar
  118. 118.
    Ginzler, A. M., and T. T. Fox: Disseminated lupus erythematosus: a cutaneous manifestation of a systemic disease (Libman-Sacks). Arch. Int. Med. 65, 26 (1940).CrossRefGoogle Scholar
  119. 119.
    Goeckerman, W. H.: Lupus erythematosus as a systemic disease. J. Amer. Med. Assoc. 80, 542 (1923).CrossRefGoogle Scholar
  120. 120.
    Goeckerman, W. H. and H. Montgomery: Lupus erythematosus: an evaluation of histopathologic examinations. Arch, of Dermat. 25, 304 (1932).CrossRefGoogle Scholar
  121. 121.
    Gold, S.: Role of sulphonamides and penicillin in the pathogenesis of systemic lupus erythematosus. Lancet 1951, 268.Google Scholar
  122. 122.
    Gold, S. An hypothesis concerning the pathogenesis of systemic lupus erythematosus. Brit. J. Dermat. 65, 43 (1953).CrossRefGoogle Scholar
  123. 123.
    Gonyea, L. M., R. A. Kallsen and A. A. ÄIarlow: The occurence of the L. E. cell in clotted blood. J. Invest. Dermat. 15, 11 (1950).Google Scholar
  124. 124.
    Gougerot, H.: Lupus érythémateux. B. Soc. franç. Dermat. 46, 971 (1939).Google Scholar
  125. 125.
    Gould, D. M., and M. L. Daves: Roentgenologic findings in systemic lupus erythema-, tosus. An analysis of 100 cases. J. Chron. Dis. 2, 136 (1955).PubMedCrossRefGoogle Scholar
  126. 126.
    Griffith, G. C., and I. L. Vural: Acute and subacute disseminated lupus erythematosus. (A correlation of clinical and postmortem findings in eighteen cases). Circulation (New York) 3, 492 (1951).Google Scholar
  127. 127.
    Gross, L.: The heart in atypical verrucous endocarditis (Libman-Sacks). Contributions to the medical sciencies in honour of Dr. Emanuel Libman by his pupils, friends and colleagues. Internat. Press 2, 527 (1932).Google Scholar
  128. 128.
    Gross, L. The cardiac lesions in Libman-Sacks disease. With a consideration of its relationship to acute diffuse lupus erythematosus. Amer. J. Path. 16. 375 (1940).PubMedGoogle Scholar
  129. 129.
    Grupper, Ch., B. Raiter, J. Hewitt, H. Dausset et H. Lavergne: Lupus érythémateux aigu. Guérison avec la Nivaquine seule (premier cas). Bull. Soc. méd. Hôp. Paris, 70, 1111 (1954).PubMedGoogle Scholar
  130. 130.
    Grünhagen, H. v.: Erythematodes chronicus bei einengen Zwillingen. Dermat. Wschr. 1952, 1089.Google Scholar
  131. 131.
    Gueft, B.: Depoiymerization of nucleic acid in acute disseminated lupus erythematosus. Arch, of Dermat. 61, 892 (1950).CrossRefGoogle Scholar
  132. 132.
    Gueft, B., and A. Laufer: Further cytochemical studies in systemic lupus erythematosus. Arch, of Path. 57, 201 (1954).Google Scholar
  133. 133.
    Hamburger, R. N.: Induction of the lupus erythematosus (“L. E.”) cell in vitro in peripheral blood. Yale J. Biol. a. Med. 22, 407 (1950).Google Scholar
  134. 134.
    Hargraves, M. M.: Production in vitro of the L. E. cell phenomenon: use of normal bone marrow elements and blood plasma from patients with acute disseminated lupus erythematosus. Proc. Staff Meet. Mayo Clin. 24, 234 (1949).PubMedGoogle Scholar
  135. 135.
    Hargraves, M. M. Lupus erythematosus. Arch, of Dermat. 62, 600 (1950).Google Scholar
  136. 136.
    Hargraves, M. M. H.Richmond and R. Morton: Presentation of two bone marrow elements; the “Tart” ceh and the “L. E.” cell. Proc. Staff Meet. Mayo Clin. 23, 25 (1948).PubMedGoogle Scholar
  137. 137.
    Harris, L. H.: Pulmonary manifestations of “rheumatoid disease”. Lancet 1954, 119.Google Scholar
  138. 138.
    Harris, E., and R. Turner: 1-Hydrazinophthalazine (Apresohne) in Hypertension. Lancet 1954, 429.Google Scholar
  139. 139.
    Harter, F., u. F. Dickgiesser: Die Agglutinationsreaktion mit sensibihsierten Hammelblutkörperchen bei chronischer Polyarthritis und weiteren Erkrankungen. Dtsch. Arch. klin. Med. 200, 202 (1953).Google Scholar
  140. 140.
    Harvey, A. M., L. E. Shulman, Ph. A. Tumulty, C. L. Conley and E. H. Schoenrich: Systemic lupus erythematosus. Review of the hterature and clinical analysis of 138 cases. Medicine 33, 291 (1954).PubMedCrossRefGoogle Scholar
  141. 141.
    Haserick, J. R.: Blood factor in acute disseminated lupus erythematosus. Arch, of Dermat. 61, 889 (1950).CrossRefGoogle Scholar
  142. 142.
    Haserick, J. R. Acute disseminated lupus erythematosus without skin lesions, diagnosed by positive observations in L. E. test. Arch, of Dermat. 63, 534 (1951).Google Scholar
  143. 143.
    Haserick, J. R. Acute disseminated lupus erythematosus, wirh negative results of L. E. test turning positive after treatment with Cortison. Arch, of Dermat. 63, 534 (1951).Google Scholar
  144. 144.
    Haserick, J. R. Plasma L. E. test in systemic lupus erythematosus. J. Amer. Med. Assoc. 146, 16 (1951).CrossRefGoogle Scholar
  145. 145.
    Haserick, J. R. Effect of Cortisone and Corticotropin on prognosis of systemic lupus erythematosus. Arch, of Dermat. 68, 714 (1953).CrossRefGoogle Scholar
  146. 146.
    Modern concepts of systemic lupus erythematosus. A review of 126 cases. J. Chron. Dis. 1, 317 (1955).CrossRefGoogle Scholar
  147. 147.
    130a. Haserick, J. R. Evaluation of three diagnostic procedures for systemic lupus erythematosus. Ann. Int. Med. 44, 497 (1956).PubMedGoogle Scholar
  148. 148.
    Haserick, J. R. and D. W. Bortz: New diagnostic test for acute disseminated lupus erythematosus. Cleveland Clin. Quart. 16, 158 (1949).Google Scholar
  149. 149.
    Haserick, J. R. Normal bone marrow inclusion phenomena induced by lupus erythematosus plasma. J. Invest. Dermat. 13, 47 (1949).Google Scholar
  150. 150.
    Haserick, J. R. A. C. Corcoran and H. Dustan: ACTH and Cortisone in the acute crisis of systemic lupus erythematosus. J. Amer. Med. Assoc. 146, 643 (1951).CrossRefGoogle Scholar
  151. 151.
    Haserick, J. R. C. Corcoran and H. Dustan and L. A. Lewis: Blood factor in acute disseminated lupus erythematosus. II. Induction of specific antibodies against L. E. factor. Blood 5, 718 (1950).Google Scholar
  152. 152.
    C. Corcoran and H. Dustan and L. A. Lewis and D. W. Bortz: Blood factor in acute disseminated lupus erythematosus. I. Determination of gamma-globulin as specific plasma fraction. Amer. J. Med. Sci. 219. 660 (1950).Google Scholar
  153. 153.
    C. Corcoran and H. Dustan and L. A. Lewis and D. W. Bortz and R. D. Sundberg: The bone marrow as a diagnostic aid in acute disseminated lupus erjrfchematosus. J. Invest. Dermat. 11, 209 (1948).Google Scholar
  154. 154.
    Hauser, W.: Über den Nachweis des L. E.-Faktors im Liquor cerebrospinalis bei Lupus erythematosus cum exacerbatione acuta des Zentralnervensystems. Med. Klin. 1951, 412.Google Scholar
  155. 155.
    Hauser, W. u. F. Geier: Chronischer Lupus erythematodes mit akuter Exacerbation und Manifestation am Zentralnervensystem. Nervenarzt 23, 181 (1952).PubMedGoogle Scholar
  156. 156.
    Hebra, F.: Z. königl. kaiserl. Ges. Ärzte Wien. 1, 40 (1845); zit. nach Kaposi.Google Scholar
  157. 157.
    Hebra, F. Hautkrankheiten, Bd. 3, 1. Teil, Wien 1845.Google Scholar
  158. 158.
    Hegglin, R.: Die Endocarditis als klinisches Problem. Verh. dtsch. Ges. Kreislaufforsch. 20, 191 (1954).Google Scholar
  159. 159.
    Hegglin, R. u. H. U. Zollinger: Klinisch-pathologisch-anatomische Demonstrationen. Cardiologia (Basel) 28, 151 (1956).Google Scholar
  160. 160.
    Heller, B. I., W. G. Jacobson und J. F. Hammersten: The effect of Cortisone m glomerulonephritis and the nephropathie of disseminated lupus erythematosus. J. Labor, a. Chn. Med. 37, 133 (1951).Google Scholar
  161. 161.
    143a. Heller, P., and H. J. Zimmerman: Nucleophagocytosis. Arch. Int. Med. 97, 403 (1956).CrossRefGoogle Scholar
  162. 162.
    Hench, P. S., E. C. Kendall, C. H. Slocumb and H. F. Polley: The effect of hormone of the adrenal cortex and of pituitary adrenocorticotropic hormone on rheumatoid arthritis. Proc. Staff Meet. Mayo Clin. 24, 181 (1949).Google Scholar
  163. 163.
    Henn, M. J., Th. W. Parkin, M. M. Hargraves and H. M. Odel: Acute systemic lupus erythematosus syndrome from Hydralazine hydrochloride. Arch. Int. Med. 95,857 (1955).CrossRefGoogle Scholar
  164. 164.
    Herzberg, J. J.: Klinische und experimentelle Beobachtungen bei dem Erythematodes acutus. Hautarzt 5, 249 (1954).Google Scholar
  165. 165.
    Hitzig, W., A. Labhart u. E. Uehlinger: Transitorische Hemmkörperhämophilie bei Rheumatismus. Helvet. med. Acta 18, 410 (1951).Google Scholar
  166. 166.
    Hollenhorst, R. W., and J. W. Henderson: The ocular manifestations of the diffuse collagen diseases. Amer. J. Med. Sci. 221, 211 (1951).PubMedCrossRefGoogle Scholar
  167. 167.
    148a. Honey, M.: Systemic lupus erythematosus presenting with Sulfonamide hypersensitivity reaction. Brit. Med. J. 1956 I, 1272.CrossRefGoogle Scholar
  168. 168.
    Humphreys, E. M.: The cardiac lesions of acute disseminated lupus erythematosus. Ann. Int. Med. 28, 12 (1948).PubMedGoogle Scholar
  169. 169.
    Huriez, CL., P. Desmons, J. Fabre, R. Voisin et M. Luez: A propos de 4 observations de lupo-érythémato-viscérite. Vili. Congrès des Dermatologistes et Syphihgraphes de langue française, 1953. Communications. G. Thomas, Nancy.Google Scholar
  170. 170.
    Inderbitzin, Th.: The experimental production of leucocytic changes in normal blood similar to L. E.-cells and morphologicy indentical with L. E.-cs. J. Invest. Dermat. 20, 67 (1953).Google Scholar
  171. 171.
    Inderbitzin, Th. Experimente Untersuchungen zur Frage der Genese der sog. L. E.-Zelle. Acta haematol. (Basel) 10, 31 (1953).CrossRefGoogle Scholar
  172. 172.
    Inderbitzin, Th. Das Lupus erythematodes-Z-Phänomen. Röntgen- und Laborpraxis 7, 189 (1954).Google Scholar
  173. 173.
    Inderbitzin, Th. Zum Problem der Deutungde.E.-Z Phänomens.Actahaematol.(Basel)12, 268(1954).CrossRefGoogle Scholar
  174. 174.
    Inderbitzin, Th. Das L. E.-Zphänomen und die Symptomatologie des akut disseminierten Lupus erythematosus. Praxis (Bern) 44, 76 (1955).Google Scholar
  175. 175.
    Isler, P., u. Chr. Hedinger: Metastasierendes Dünndarmcarcinoid mit schweren, vorwiegend das rechte Herz betreffenden Klappenfehlern und Pulmonalstenose — ein eigenartiger Sjrmptomenkomplex. Schweiz, med. Wschr. 1953, 4.Google Scholar
  176. 176.
    Israel, H. L.: The pulmonary manifestations of disseminated lupus erythematosus. Amer. J. Med. Sci. 226, 387 (1953).PubMedCrossRefGoogle Scholar
  177. 177.
    Jacobs, H. J.: Acute disseminated lupus erythematosus with hemolytic anemia in a 10-year-old child. J. of Pediatr. 42, 728 (1953).CrossRefGoogle Scholar
  178. 178.
    Jadassohn, J.: Lupus erythematodes. Handbuch der Hautkrankheiten v. F. Mracek, Bd. 3, S. 298. Wien 1904.Google Scholar
  179. 179.
    Jasinski, B., G. E. Stiefel, H. Märki sen. u. F. Wuhrmann: Über ein dem Lupus erythematodes-Phänomen ähnliches Zellbüd im Cantharidenblaseninhalt und seine Beziehungen zu den Gamma-Globuhnen. Khn. Wschr. 1953, 252.Google Scholar
  180. 180.
    Jausion, H., R. Massari, P. Benard et G. Kouchner: Sur un nouveau cas de lupus érythémateux subaigu à forme polyarticulaire. VIII Congrès des Dermatologistes et Syphihgraphes de langue française 1953. Communications, G. Thomas, Nancy.Google Scholar
  181. 181.
    Jessar, r. a., r. W. Lamont-Havres and C. Ragan: Natural history of lupus erythematosus disseminatus. Ann. Int. Med. 38, 717 (1953).PubMedGoogle Scholar
  182. 182.
    Johnson, S., O. Meyer, J.W.Brown and A. F. Rasmussen jr.: Failure of Chloramphenicol in the treatment of three cases of lupus erythematosus disseminatus. J. Invest. Dermat. 14, 305 (1950).Google Scholar
  183. 183.
    Johnson, H. M.: Effects of splenectomy in acute systemic lupus erythematosus. Arch, of Dermat. 68, 699 (1953).CrossRefGoogle Scholar
  184. 184.
    JKE, R. A., and W. E. King: The “L. E.-cell” Phenomenon in active chronic viral hepatitis. Lancet 1955, 477.Google Scholar
  185. 185.
    Kaposi, M. K.: Neue Beiträge zur Kenntnis des Lupus erythematosus. Arch. f. Dermat. 4, 36 (1872).Google Scholar
  186. 186.
    Keefer, C. S., and A. R. Felty: Acute disseminated lupus erythematosus. Report of three fatal cases. B. Johns Hopkins Hosp. 35, 294 (1924).Google Scholar
  187. 187.
    Keil, H.: Relationship between lupus erythematosus and tuberculosis; a critical review based on observations at necropsy. Arch, of Dermat. 28, 765 (1933).CrossRefGoogle Scholar
  188. 188.
    Keil, H. Relation between “systemic” lupus erythematosus and a peculiar form of thrombocytopenic purpura. Brit. J. Dermat. 49, 221 (1937).CrossRefGoogle Scholar
  189. 189.
    Keil, H. Conception of lupus erythematosus and its morphologic variants. (With particular reference to “systemic” lupus erythematosus disseminatus). Arch, of Dermat. 36,729 (1937).CrossRefGoogle Scholar
  190. 190.
    Keil, H. Dermatomyositis and systemic lupus erythematosus. I. A clinical report of “transitional” case, with a consideration of lead as a possible etiologie factor. Arch. Int. Med. 66,109 (1940).CrossRefGoogle Scholar
  191. 191.
    Dermatomyositis and systemic lupus erythematosus. II A comparative study of the essential chnicopathologic features. Arch. Int. Med. 66, 339 (1940).CrossRefGoogle Scholar
  192. 192.
    Keining, H., et Ch. Brett: Symptômes neurologiques et ophthalmologiques remarquables constatés dans un cas d’Erythematodes cum exacerbatione acuta à issue morte. VIII. Congrès des Dermatologistes et Syphihgraphes de langue française, 1953. Communications, G. Thomas, Nancy.Google Scholar
  193. 193.
    Keith, N. M.: The renal problem in lupus erythematosus. Proc. Staff Meet. Mayo Clin. 15, 682 (1940).Google Scholar
  194. 194.
    Kierland, R. R., L. A. Brijnsting and O’Leary P. A.: Quinacrine hydrochloride in the treatment of lupus erythematosus. Proc. Staff Meet. Mayo Clin. 28, 636 (1953).Google Scholar
  195. 195.
    Klein, E.: Lupus erythematodes viscerahs sive disseminatus. Dtsch. med. Wschr. 1955,226.Google Scholar
  196. 196.
    Klemperer, P.: The pathogenesis of lupus erythematosus and allied conditions. Ann. Int. Med. 28, 1 (1948).PubMedGoogle Scholar
  197. 197.
    Klemperer, P. Concept of cohagen diseases. Amer. J. Path. 26, 505 (1950).PubMedGoogle Scholar
  198. 198.
    Klemperer, P. Changing patterns in the definition of acute lupus erythematosus. J. Mount Sinai Hosp. 17, 793 (1950/1951).Google Scholar
  199. 199.
    Klemperer, P. Über fibrinoide Substanzen. Wien. Hin. Wschr. 1953, 713.Google Scholar
  200. 200.
    Klemperer, P. B. Gueft and S. Lee: Nucleic acid depoiymerization in systemic lupus erythematosus. J. Mount Smai Hosp. 16, 61 (1949).Google Scholar
  201. 201.
    Klemperer, P. C. Leuchtenberger and A. W. Pollister: Cjrtochemical changes of acute lupus erythematosus. Arch, of Path. 49, 503 (1950).Google Scholar
  202. 202.
    D. Pollack and G. Baehr: Pathology of disseminated lupus ervthematosus. Arch, of Path. 32, 569 (1941).Google Scholar
  203. 203.
    D. Pollack and G. Baehr Diffuse cohagen disease. Acute disseminated lupus erythematosus and diffuse scleroderma. J. Amer. Med. Assoc. 119, 331 (1942).CrossRefGoogle Scholar
  204. 204.
    Klinge, P.: Der Rheumatismus; pathologisch-anatomische und experimentell-pathologische Tatsachen und ihre Auswertung für das ärzthche Rheumaproblem. Erg. Path. 27, 1 (1933).Google Scholar
  205. 205.
    Kofman, S., G. C. Johnson and H. J. Zevimerman: Apparent hepatic dysfunction in lupus erythematosus. Arch. Int. Med. 95, 669 (1955).CrossRefGoogle Scholar
  206. 206.
    Körting, G. W., and R. Schmitz: Induktion des Lupus erythematodes-Zellphänomens mittels Urin. Dermat. Wschr. 1952, 174.Google Scholar
  207. 207.
    Krupp, M. A.: Urinary sediment in visceral angiitis (Periarteriitis nodosa, Lupus erythematosus, Libman-Sacks-Disease). Arch. Int. Med. 71, 54 (1943).CrossRefGoogle Scholar
  208. 208.
    187a. Kull, E., u. A. Briner: Erste Erfahrungen mit einer neuen Technik zum Nachweis phagocytärer Phänomene (L. E.-Zeh-Phänomene). Schweiz, med. Wschr. 1956, 506.Google Scholar
  209. 209.
    Kurnick, N. B.: The determination of desoxyribonuclease activity by methyl green; application to serum. Arch, of Biochem. 29, 41 (1950).Google Scholar
  210. 210.
    188a. D. Pollack and G. Baehr A rational therapyof systemic lupus erythematosus. Arch. Int. Med. 97, 562 (1956).CrossRefGoogle Scholar
  211. 211.
    D. Pollack and G. Baehr S. Pariser, L. I. Schwartz, S. L. Lee and W. Irvine: Studies on desoxyribonuclease in systemic lupus erythematosus. J. Clin. Invest. 31, 1036 (1952).CrossRefGoogle Scholar
  212. 212.
    D. Pollack and G. Baehr L. I. Schwartz, S. L. Lee and W. Irvine The role of desoxyribonuclease and a nuclease inhibitor from leucocytes in the lupus erythematosus cell phenomenon. J. Clin. Invest. 31, 645 (1952).Google Scholar
  213. 213.
    D. Pollack and G. Baehr L. I. Schwartz, S. L. Lee and W. Irvine A specific inhibitor for human desoxyribonuclease and an inhibitor of the lupus erythematosus cell phenomenon from leucocytes. J. Chn. Invest. 32, 193 (1953).CrossRefGoogle Scholar
  214. 214.
    Kuypers, C. a.: Ein mit Atebrin behandelter Fall von Lupus erythematosus disseminatus subacutus. Nederl. Tijdschr. Geneesk. 1953, 818.Google Scholar
  215. 215.
    Laszlo, M. H., a. Alvarez and F. Feldman: The association of thrombotic thrombocytopenic purpura and disseminated lupus erythematosus. Report of a case. Ann. Int. Med. 42, 1308 (1955).PubMedGoogle Scholar
  216. 216.
    193a. Lee, St. L.: A simple test for L. E. cells. Amer. J. Clin. Path. 21, 492 (1951).Google Scholar
  217. 217.
    193b. Lee, St. L Clinical experiences wüh the L. E. ceh test. J. Mount Sinai Hosp. 22, 74 (1955).Google Scholar
  218. 218.
    Lee, St. L S. R. Michael and I. L. Vural: The L. E. (Lupus erythematosus) ceh. Chnical and chemical studies. Amer. J. Med. 10, 446 (1951).PubMedCrossRefGoogle Scholar
  219. 219.
    Lee, St. L L. I. Schwartz and S. Pariser: Blood coagulation and the L. E. Cell Phenomenon. Blood 9, 965 (1954).Google Scholar
  220. 220.
    Lee, St. L M. Sanders and H. M. Kahny: A disorder of blood coagulation in systemic lupus erythematosus. J. Clin. Invest. 34, 1814 (1955).PubMedCrossRefGoogle Scholar
  221. 221.
    Legobbe, E.: Familiärer Erythematodes (2 Todesfähe; bei einer Beobachtung tuberkuloser Organbefund). Dermat. Wschr. 1937, 1145.Google Scholar
  222. 222.
    Leoni, A.: A proposito della specifità del fenomeno L. E. Minerva med. (Torino) 45, vol. 1 (1954).Google Scholar
  223. 223.
    Ley, A. B., G. G. Reader, C. W. Sorennson and R. S. Overman: Idiopathic hypo-prothrombinemia associated with hemorrhagic diathesis, and the effect of vitamin K. Blood 6, 740 (1951).PubMedGoogle Scholar
  224. 224.
    Lian, C., et P. Danset: Les lupo-érythémateux-viscérites mahgnes. Notions cardio- logiques nouvehes. Paris: Masson & Cie 1951.Google Scholar
  225. 225.
    Lian, C., F. Siguier, B. Duperrat et A. Sarrazin: Lupo-érythemateux viscérite maligne à évolution fatale malgré une penicothérapie massive (observation anatomoclinique). Buh. Soc. méd. Hôp. Paris 63, 193 (1947).Google Scholar
  226. 226.
    Lian, C., F. Siguier, B. Duperrat et A. Sarrazin et A. Sarrazin: Les lupo-érythémato-viscérites mahgnes (élargissement noso-graphique de la «maladie» de Libman-Sacks). Bull. Soc. méd. Hôp. Paris 63, 167 (1947).Google Scholar
  227. 227.
    Libman, E.: Characterization of various forms of endocarditis. J. Amer. Med. Assoc. 80, 813 (1923).CrossRefGoogle Scholar
  228. 228.
    Libman, E. The varieties of endocarditis and their clinical significance. Trans. Assoc. Amer. Physicians 53, 345 (1938).Google Scholar
  229. 229.
    Libman, E. and B. Sacks: A hitherto undescribed form of valvular and mural endocarditis. Arch. Int. Med. 33, 701 (1924).CrossRefGoogle Scholar
  230. 230.
    Liebow, J. M., and H. Feil: The electrocardiogram in lupus erythematosus disseminatus. Amer. J. Med. 3, 44 (1947).PubMedCrossRefGoogle Scholar
  231. 231.
    Lincoln, M., and W. A. Rickeb: A case of periarteritis nodosa with L. E. cells. Apparent complete remission with Cortisone therapy. Ann. Int. Med. 41, 639 (1954).PubMedGoogle Scholar
  232. 232.
    Löffler, W.: Endocarditis parietalis fibroplastica mit Bluteoshiophilie. Schweiz, med. Wschr. 1936, 817.Google Scholar
  233. 233.
    Löffler, Ch. W.: Endocarditis. Trans. Amer. Hunt. Soc. 10, 73 (1951/1952).Google Scholar
  234. 234.
    Löffler, W., u. C. Maier: Über einen Fall von FELTYschem Syndrom mit cyclischer Agranulozytose. Cardiologia (Basel) 12, 195 (1947).Google Scholar
  235. 235.
    209a. Loghem van, J. J.: Colloque sur l’immunologie des leucocytes et des plaquettes. Paris, 17. 1. 1955.Google Scholar
  236. 236.
    Löhlein, M.: Über hämorrhagische Nierenaffektionen bei chronischer ulzeröser Endocarditis (embolische nichteitrige Herdenephritis). Med. Klin. 1910, 375.Google Scholar
  237. 237.
    Lowman, E. W., and Ch. H. Slocumb: The peripheral vascular lesions of lupus erythematosus. Ann. Int. Med. 36, 1206 (1952).PubMedGoogle Scholar
  238. 238.
    Madden, J. F.: Acute disseminated lupus erythematosus. Arch, of Dermat. 25, 854 (1932).CrossRefGoogle Scholar
  239. 239.
    Madden, J. F. Comparison of muscle biopsies and bone marrow examinations in dermatomyositis and lupus erythematosus. Arch, of Dermat. 62, 192 (1950).CrossRefGoogle Scholar
  240. 240.
    213a. Marchionini, A., u. W. Thies: Erythematodes. Ätiologie, Pathogenese und Therapie. Münch, med. Wschr. 1956, 293.Google Scholar
  241. 241.
    Marmont, A.: Beobachtungen über das sogenannte L. E.-Phänomen. Schweiz, med. Wschr. 1952, 1111.Google Scholar
  242. 242.
    Marmont, A. Observations et remarques sur le phénomène L. E. VIII. Congrès des Dermatologistes et Syphihgraphes de langue française, 1953. p. 54. Communications G. Thomas, Nancy.Google Scholar
  243. 243.
    Marmont, A. Valore e significato biologico del cosidetto “fenomeno L. E.” n’eritematode sistemico acuto. Mmerva med. (Tormo) 44, 80 (1953).Google Scholar
  244. 244.
    Marmont, A. Esperienze e resultati nel trattamento con ACTH e Cortisone del lupus eritematoso acuto disseminato. Symposium Europeo sul Cortisone, Redi, Milano 1954.Google Scholar
  245. 245.
    Marmont, A. Value and hmitations of the L. E. c test in the syndrome known as systemic lupus erythematosus without skin eruptions. Acta haematol. (Basel) 13, 257 (1955).CrossRefGoogle Scholar
  246. 246.
    Marmont, A. Persönliche Mitteilung.Google Scholar
  247. 247.
    Marmont, A. and S. Giacca: Heterophil red cell agglutination in a case of acute systemic lupus erythematosus. Vox Sanguinis 5, 38 (1955).Google Scholar
  248. 248.
    Mathis, H. B.: A simple office procedure for demonstrating lupus erythematosus cs m peripheral blood. Blood 6, 470 (1951).PubMedGoogle Scholar
  249. 249.
    Matthews, H. L., and M. J. Meynell: Acute diffuse lupus erythematosus. Report of a case with predominant pulmonary manifestations. Brit. Med. J. 1954 II, 1140.Google Scholar
  250. 250.
    McCreight, W. G., and H. Montgomery: Cutaneous changes in lupus erythematosus. Histopathologic aspects with special reference to vascular changes. Arch, of Dermat. 61, 1 (1950).CrossRefGoogle Scholar
  251. 251.
    Meacham, G. C., and A. S. Weisberger: Unusual manifestations of disseminated lupus erythematosus. Ann. Int. Med. 43, 143 (1955).PubMedGoogle Scholar
  252. 252.
    Merrell, M., and L. E. Shulman: Determination of prognosis in chronic disease, ustrated by systemic lupus erythematosus. J. Chron. Dis. 1, 12 (1955).PubMedCrossRefGoogle Scholar
  253. 253.
    Míale, J. B.: Characteristic urinary findmgs in visceral angiitis. (Periateriitis nodosa, lupus erytmheatosus). Amer. J. Chn. Path. 17, 820 (1947).Google Scholar
  254. 254.
    Michael, S. R., I. L. Vural, F. A. Bassen and L. Schaefer: The hematologic aspects of disseminated (systemic) lupus erythematosus. Blood 6, 1059 (1951).PubMedGoogle Scholar
  255. 255.
    Michelson, H. E.: Review and appraisal of present knowledge concerning lupus erythematosus. Arch, of Dermat. 69, 694 (1954).CrossRefGoogle Scholar
  256. 256.
    Miescher, G.: Erfahrungen mit Cortison und ACTH. Praxis (Bern) 41, 64 (1952).Google Scholar
  257. 257.
    Miescher, P.: Nucléophagocytose et phénomène L. E. Schweiz, med. Wschr. 1953,1042.Google Scholar
  258. 258.
    Marmont, A. et J. Delacretaz: Demonstration d’un phénomène «L. E.», positü dans deux cas d’hypersensibilité médicamenteuse. Schweiz, med. Wschr. 1953, 536.Google Scholar
  259. 259.
    Marmont, A. et M. Fauconnet: L’absorption du facteur «L. E. » par des noyaux cellulaires isolés. Experientia (Basel) 10, 252 (1954).CrossRefGoogle Scholar
  260. 260.
    232a. Moeschlin, S.: Der heutige Stand der ACTH-, Cortison- und Prednison-Therapie. Schweiz, med. Wschr. 1956, 81.Google Scholar
  261. 261.
    Moffatt, T. W., S. S. Barnes and R. S. Weiss: The induction of the L. E. ceh (Hargraves) in normal peripheral blood. J. Invest. Dermat. 14,153 (1950).Google Scholar
  262. 262.
    Montgomery, H.: The pathology of lupus erythematocus. J. Invest. Dermat. 2,343 (1939).CrossRefGoogle Scholar
  263. 263.
    Montgomery, H. and W. G. McCreight: Disseminated lupus erythematosus. Arch, of Dermat. 60, 356 (1949).CrossRefGoogle Scholar
  264. 264.
    Morrow, J. D., H. A. Scbhoeder and H. M. Perry: Studies on the control of hypertension by Hyphex: II. Toxic reactions and side effects. Circulation (New York) 8, 829 (1953).Google Scholar
  265. 265.
    Moschcowitz, E.: An acute febrile pleiochromic anemia with hyaline thrombosis of the terminal arterioles and capiharies; an undescribed disease. Arch. Int. Med. 36, 89 (1925).CrossRefGoogle Scholar
  266. 266.
    Moskovitz, R.: Libman-Sacks disease. J. Mount Sinai Hosp. 73, 143 (1946).Google Scholar
  267. 267.
    Moyer, J. B., and G. S. Fisher: Experimental production of “L. E.” cells. Amer. J. Clin. Path. 20, 1011 (1950).Google Scholar
  268. 268.
    Müller, U.: Experimentehe Untersuchungen über Iso- und Autohämopsonine. Helvet. med. Acta 21, 550 (1954).PubMedGoogle Scholar
  269. 269.
    Müller, W., u. B. Radojicic: Vorkommen leukocytenagglutinierender und thrombocytarer Antikörper bei einem Fah von akutem Lupus erythematosus disseminatus. Klin. Wschr. 34, 577 (1956).PubMedCrossRefGoogle Scholar
  270. 270.
    Nelson, R. A. jr., and M. M. Mayer: Immobüization of treponema pahidum in vitro by antibody produced in syphihtic infection. J. of Exper. Med. 89, 369 (1949).CrossRefGoogle Scholar
  271. 271.
    Neumann, F.: Lupus erythematosus. Wien. med. Wschr. 1863, 287.Google Scholar
  272. 272.
    Neuss, O.: Familiäres und endemisches Vorkommen von Kollagenkrankheiten mit besonderer Berücksichtigung von Lupus erythematosus disseminatus mit Periateriitis nodosa. Medizinische 1955, 426.Google Scholar
  273. 273.
    Nilsson, I. M., and A. Wenckert: Hyperglobulüiemia as the cause of hemophilia-like disease. Blood 8, 1067 (1953).PubMedGoogle Scholar
  274. 274.
    Osler, W.: On the visceral complication of erythema exsudativum multiforme. Amer. J. Med. Sci. 110, 629 (1895).CrossRefGoogle Scholar
  275. 275.
    Osler, W. On the visceral manifestations of the erythema group of skin diseases. Amer. J. Med. Sci. 127, 1 (1904).CrossRefGoogle Scholar
  276. 276.
    Osterwald, K., u. H. Frank: Über das Libman-Sacks-Syndrom. Ärztl. Wschr. 1953, 125.Google Scholar
  277. 277.
    Page, F.: Treatment of lupus erythematosus with Mepacrine. Lancet 1951, 755.Google Scholar
  278. 278.
    Parkes, E. A.: A practical treatise on diseases affecting the skin. London 1850; zit. nach Kaposi.Google Scholar
  279. 279.
    Pautrier, L. M.: Les lupus érythémateux aigus. Formes cliniques. Considérations générales. VIII. Congrès des Dermatologistes et Sjrphihgraphes de langue française, p. 121, 1953, Rapports. G. Thomas, Nancy.Google Scholar
  280. 280.
    Perry, H., and H. Schroeder: Syndrome simulating collagen disease caused by Hydralazine (Apresohne). J. Amer. Med. Assoc. 154, 670 (1954).CrossRefGoogle Scholar
  281. 281.
    Piguet, B.: Le lupus érythémateux disséminé. Etude chnique et thérapeutique. Semaine Hôp. 1955, 327.Google Scholar
  282. 282.
    252a. Pisciotta, A. V., J. J. Giliberti, T. J. Greenwalt and W. W. Engstrom: Acute hemolytic anemia in disseminated lupus erythematosus. Treatment with Cortisone. Report of a case. Amer. J. Clin. Path. 21, 1139 (1951).Google Scholar
  283. 283.
    Plötz, Ch. M., E. L. Howes, J. W. Blunt, K. Meyer and Ch. Ragan: Action of Cortisone on mesenchymal tissues. Arch, of Dermat. 61, 919 (1950).CrossRefGoogle Scholar
  284. 284.
    J. W. Blunt and Ch. Ragan: Effect of pituitary adrenocorticotropic hormone (ACTH) on disseminated lupus erythematosus. Ärch. of Dermat. 61, 913 (1950).CrossRefGoogle Scholar
  285. 285.
    Pollister, A. W., and C. Leuchtenberger: The nature of the specüity of methyl green for chromatin. Proc. Nat. Acad. Sci. 2, 111 (1949).CrossRefGoogle Scholar
  286. 286.
    Prunty, F. T. G.: Recrudescence of tuberculosis in acute disseminated lupus erythematosus. Proc. Roy. Soc. Med. (London) 45, 171 (1952).Google Scholar
  287. 287.
    Purnell, D. C., A. H. Baggenstoss and A. M. Olsen: Pulmonary lesions in disseminated lupus erythematosus. Ann. Int. Med. 42, 619 (1955).PubMedGoogle Scholar
  288. 288.
    Rakov, H. L., and J. S. Taylor: Acute disseminated lupus erythematosus with cutaneous manifestations and with heretofore undescribed pulmonary lesions. Arch. Int. Med. 70, 88 (1942).CrossRefGoogle Scholar
  289. 289.
    Rayer, P.: Traité théorique et pratique des maladies de la peau. Vol. 2. p. 246. Paris 1827; zit nach Cohen u. Cadman..Google Scholar
  290. 290.
    Rebuck, j. w., and L. Berman: Experimental production of the L. E. phenomenon in the skm of man. Proc. Soc. Exper. Biol. a. Med. 75, 259 (1950).Google Scholar
  291. 291.
    Reifenstein, E. C., E. C. Reifenstein jr. and C. H. Reifenstein: A variable symptom complex of undetermined etiology with fatal termination. Arch. Int. Med. 63, 551 (1939).CrossRefGoogle Scholar
  292. 292.
    Rein, Ch. R., and G. H. Kost ant: Lupus erythematosus: serologic and chemical aspects. Arch, of Dermat. 61, 898 (1950).CrossRefGoogle Scholar
  293. 293.
    Reinhabdt, D. J., and J. M. Waldron: Lupus erythematosus-like syndrome complicating Hydralazine (Apresoline) therapy. J. Amer. Med. Assoc. 155, 1491 (1954).CrossRefGoogle Scholar
  294. 294.
    Rich, A. R.: Hypersensitivity in disease. Harvey Lectures, Series 42, pp. 106–142. Springfield,.: Charles C. Thomas 1946/1947.Google Scholar
  295. 295.
    Rich, A. R. and J. E. Gregory: Experimental anaphylactic lesions of the coronary arteries of the “sclerotic type”, commonly associated with rheumatic fever and disseminated lupus erythematosus. Bull. Johns Hopkins Hosp. 81, 312 (1947).PubMedGoogle Scholar
  296. 296.
    Richards, D. G.: Three cases of collagen disease treated with corticoids. Brit. Med. J. 1954 II, 777.CrossRefGoogle Scholar
  297. 297.
    Richter, R.: Klinische xmd theoretische Bemerkungen zur ACTH-Behandlung der Kagenosen. Hautarzt 3, 365 (1952).PubMedGoogle Scholar
  298. 298.
    Riva, G., u. F. Schertenleib Mesenchymale Reaktionen als zweite Krankheit. (Bemerkungen zu 4 posttraumatischen und postoperativen Fen von Gelenkrheumatismus bzw. Sklerodermie). Helvet. med. Acta. 17, 550 (1950).PubMedGoogle Scholar
  299. 299.
    Robb-Smith, A. H. T.: The concept of the cagen diseases. Practitioner 173, 117 (1954).PubMedGoogle Scholar
  300. 300.
    Rose, E., and D. M. Pillsbitry: Acute disseminated lupus erythematosus a systemic disease. Ann. Int. Med. 12, 951 (1939).Google Scholar
  301. 301.
    Rose, H. M., Ch. Ragan, E. Pearce and M. O. Libman: Zit. nach Harter und Dick- giesser: Proc. Soc. Exper. Biol. a. Med. 70, 650 (1948).Google Scholar
  302. 302.
    Ross, S. W., and B. B. Wells: Systemic lupus erythematosus. A review of the Utera- ture. Amer. J. Clin. Path. 23, 139 (1953).Google Scholar
  303. 303.
    Rossi, E.: Die Fibroelastosis endocardia im Säuglingsalter. Moderne Probleme der Pädiatrie. Vol. 1, S. 799, 1954.Google Scholar
  304. 304.
    Rossi, E. Herzkrankheiten im Säungsalter. Stuttgart: Georg Thieme 1955.Google Scholar
  305. 305.
    Russell, P. W., J. R. Haserick and E. M. Zucker: Epüepsy in systemic lupus erythematosus. Effect of Cortisone and ACTH. Arch. Int. Med. 88, 78 (1951).CrossRefGoogle Scholar
  306. 306.
    275a. Saathoff, J., u. H. Kusel: Leukocytenagglutination bei Pyramidon-agranulocytose, Lupus erythematosus und einem chronischen Rheumatismus. Dtsch. Arch. klin. Med. 201, 229 (1954).PubMedGoogle Scholar
  307. 307.
    Sante, L. R., and J. P. Wyatt: Roentgenological and pathological observations in antigenetic pneumonitis. Amer. J. Roentgenol. 66, 627 (1951).Google Scholar
  308. 308.
    Sarrazin, Â.: La lupo-érythémato-viscérite mgne. Thèse, Paris 1949.Google Scholar
  309. 309.
    Scheidgger, S.: Libman-sacks-Syndrom. Schweiz. Z. Path. 9, 669 (1946).Google Scholar
  310. 310.
    278a. Schleicher, E. M.: L.E. cells in sections of marrow units. Acta haemat. 10, 337 (1953).PubMedCrossRefGoogle Scholar
  311. 311.
    278b. Schreuss, H. Th.: Sexualhormone bei Erythematodes acutus. Medizinische 1953, 1482.Google Scholar
  312. 312.
    Schuermann, H.: Fortschritte der praktischen Dermatologie und Venerologie. Berlin- Göttingen-Heidelberg: Springer-Verlag 1952.Google Scholar
  313. 313.
    Schuermann, H. u. R. Doepfmer: Behandlung des Lupus erythematodes acutus mit ACTH. Hautarzt 1, 421 (1950).Google Scholar
  314. 314.
    Schuermann, H. u. R. Doepfmer u. W. Hauser: Über die Hargraves-Haserick-(„L. E.”)-Zelle (insbesondere im Sternalmark) beim Lupus erythematosus acutus. Hautarzt 1, 557 (1950).Google Scholar
  315. 315.
    Schuppli, R.: Erythematodes. Lit.-Übersicht über das Jahr 1952. Dermatologica (Basel) 106, 332 (1953).Google Scholar
  316. 316.
    Schwarz, L.: Zur Differentialdiagnose und Therapie des akut verlaufenden Lupus erythematosus. Med. Klin. 1952, 91.Google Scholar
  317. 317.
    Seaman, A. J., and J. W. Christerson: Demonstration of L. E. cells in pericardial fluid. J. Amer. Med. Assoc. 149, 145 (1952).CrossRefGoogle Scholar
  318. 318.
    Selye, H.: The alarm reaction and the diseases of adaptation. Ann. Int. Med. 29, 403 (1948).PubMedGoogle Scholar
  319. 319.
    Selye, H. Stress (The physiology and pathology of exposure to stress.) Montreal 1950.Google Scholar
  320. 320.
    Serri, f., et C. C. Tmozzi: L’Atebrine dans le traitement du lupus érjrfchémateux. VIII. Congrès des Dermatologistes et Syphihgraphes de langue française, p. 73, 1953. Communications, G. Thomas, Nancy.Google Scholar
  321. 321.
    Shackman, N. H., A. I. Swiller and M. Morrison: Syndrome simulating acute Hydralazine (Apresoline) therapy. J. Amer. Med. Assoc. 155, 1492 (1955).CrossRefGoogle Scholar
  322. 322.
    Shearn, m. a., and B. Pirofsky: Disseminated lupus erythematosus. Analysis of 34 cases. Arch. Int. Med. 90, 790 (1952).CrossRefGoogle Scholar
  323. 323.
    Siegenthaler, W.: Der viscerale Lupus erythematosus. (Libman-Sacks-Syndrom). Schweiz, med. Wschr. 1954, 163.Google Scholar
  324. 324.
    Siegmund, H.: Zur Pathologie der chronischen Streptokokkensepsis. Münch, med. Wschr. 1925, 639Google Scholar
  325. 325.
    Silver, H.: Sjnnposium on lupus erythematosus. Including recent developments in diagnosis and treatment. Lupus erythematosus (Introduction to the subject). Arch, of Dermat. 61, 887 (1950).CrossRefGoogle Scholar
  326. 326.
    Slocumb, C. H.: Arthalgia and arthritis of lupus erythematosus. Proc. Staff Meet. Mayo Clin. 15, 683 (1940).Google Scholar
  327. 327.
    Slonim, N. B.: Arthralgia, headache, prostration and fever during Hydralazine therapy. J. Amer. Med. Assoc. 154, 1419 (1954).CrossRefGoogle Scholar
  328. 328.
    Snapper, I., and D. J. Nathan: The mechanics of the L. E. ceh phenomenon, studied with a simphfied test. Blood 10, 718 (1955).Google Scholar
  329. 329.
    Soffer, L. J., S. K. Elster and D. J. Hamerman: Treatment of acute disseminated lupus erythematosus with Corticotropin and Cortisone. Arch. Int. Med. 93, 503 (1954).CrossRefGoogle Scholar
  330. 330.
    Soffer, L. J., S. K. Elster and D. J. Hamerman M. F. Levitt and G. Baehr: Use of Cortisone and adrenocorticotropic hormone in acute disseminated lupus erythematosus. Arch. Int. Med. 85, 558 (1950).CrossRefGoogle Scholar
  331. 331.
    Soffer, L. J., S. K. Elster and D. J. Hamerman and R. Bader: Corticotropin and Cortisone in acute disseminated lupus erythematosus; results of longterm use. J. Amer. Med. Assoc. 149,1002 (1952).CrossRefGoogle Scholar
  332. 332.
    Spühler, O., u. L. Morandi: Sklerodermie und ihre Beziehungen zu Libman-Sacks- Syndrom, Dermatomyositis und rheumatischem Infektionskreis. Helvet. med. Acta 15, 147 (1949).Google Scholar
  333. 333.
    299a. Steinberg, Ch., Le Roy and A. I. Roodenburg: Metacortandracin (Meticorten) in the treatment of disseminated lupus erythematosus and periarteritis nodosa. Ann. Int. Med. 44, 316 (1956).PubMedGoogle Scholar
  334. 334.
    Stickney, J. M., and N. M. Keith: Renal involvement in disseminated lupus erythematosus. Arch. Int. Med. 66, 643 (1940).CrossRefGoogle Scholar
  335. 335.
    Stokes, J. H., H. Beerman and N. R. Ingraham: The “lupus erythematosus” concept: an attempt of integration. Amer. J. Med. Sci. 207, 540 (1944).Google Scholar
  336. 336.
    Stokes, J. H., H. Beerman and N. R. Ingraham H. Beerman and N. R. Ingraham jr.: The L. E. cell and phenomenon in lupus erythematosus. Amer. J. Med. Sci 222, 473 (1951).CrossRefGoogle Scholar
  337. 337.
    Suksta, A., and C. L. Conley: Some observations on the L. E. cell. J. Labor, a. Clin. Med. 37, 597 (1951).Google Scholar
  338. 338.
    Sundberg, R. D., and N. B. Lick: “L. E.” cells in the blood in acute disseminated lupus erythematosus. J. Invest. Dermat. 12, 83 (1949).Google Scholar
  339. 339.
    Tappeiner, S.: Das Syndrom des Erythematodes acutus. Arch. f. Dermat. 190, 143 (1950).Google Scholar
  340. 340.
    Taubenhaus, M., B. Eisenstein and A. Pick: Cardiovascular manifestations of cohagen disease. Circulation (New York) 12, 903 (1955).Google Scholar
  341. 341.
    Teilum, G.: Pathogenetic studies on lupus erythematosus disseminatus and related diseases. Acta med. scand. (Stockh.) 123, 126 (1946).CrossRefGoogle Scholar
  342. 342.
    Teilum, G. Hyperglobulinemia, periarterial fibrosis of the spleen and the wire loop lesions in disseminated lupus erythematosus in relation to ahergic pathogenesis. Amer. J. Path. 24, 409 (1948).PubMedGoogle Scholar
  343. 343.
    Thiers, H., et D. Colomb: Résultats comparés du traitement d’un lupus érythémateux subaigu par la Cortisone et l’Isoniazide. VIII. Congrès des Dermatologistes et Syphihgraphes de langue française 1953. Communications, G. Thomas, Nancy.Google Scholar
  344. 344.
    Thorel, E., et Ch. Belz: Lupo-érythémato-viscérite maligne avec néphrite traitée par l’ACTH. VIII. Congrès des Dermatologistes et Syphihgraphes de langue française 1953. Communications, G. Thomas, Nancy.Google Scholar
  345. 345.
    Thorell, I.: Pulmonary changes in caes of disseminated lupus erythematosus. Acta radiol. (Stockh.) 37, 8 (1952).Google Scholar
  346. 346.
    Thorn, G., P. H. Forsham, T. P. Prawley, S. R. Hill, M. Roche, D. Staehelin and D. L. Wilson: The chnical usefulness of ACTH and Cortisone. New England J. Med. 242, 787 (1950).Google Scholar
  347. 347.
    Tobler, H.: Über einen Fall von Libman-SACKSscher Krankheit. Helvet. paediatr. Acta 1, 515 (1946).Google Scholar
  348. 348.
    Traub, E. F., and H. J. Spoor: Metabohc and steroid hormone changes in lupus erythematosus. Arch, of Dermat. 63, 24 (1951).CrossRefGoogle Scholar
  349. 349.
    Trubowitz, S.: The sternal marrow aspiration of amyloid in multiple myeloma. Blood 5, 581 (1950).PubMedGoogle Scholar
  350. 350.
    Tumulty, P. A.: The chnical course of systemic lupus erythematosus. J. Amer. Med. Assoc. 156, 947 (1954).CrossRefGoogle Scholar
  351. 351.
    Tumulty, P. A. and A.M. Harvey: The chnical course of disseminated lupus erythematosus; an evaluation of Osler’s contributions. Bull. Johns Hopkins Hosp. 85, 47 (1949).Google Scholar
  352. 352.
    Tumulty, P. A. M. Berthrong and A. McGehee-Harvey: A peculiar pneumonia associated with retinal cystoid bodies. Bull. Johns Hopkins. Hosp. 88, 239 (1951).PubMedGoogle Scholar
  353. 353.
    Van Doormaal, T. A. J., and J. T. R. Schreuder: Über die sog. Eythematodes-Zehe und deren Vorkommen in der Pleuraflüssigkeit bei einer an „Lupus erythematodes disseminatus (subacutus)“ leidenden Patientin. Dermatologica (Basel) 101, 167 (1951).CrossRefGoogle Scholar
  354. 354.
    Veiel, f.: Lupus erythematodes in J. Jadassohn, Handbuch der Haut- und Geschlechtskrankheiten, S. 687. Berlin: Juhus Springer 1931.Google Scholar
  355. 355.
    Vilanova, X.: Atebrin and Chloroquin (Resochin) in der Behandlung des Erythematodes und der durch Lichtempfindlichkeit hervorgerufenen Dermatosen. Klin. Wschr. 1954, 905.Google Scholar
  356. 356.
    Volkman-Zehr, M.: Das sog. Libman-Sacks Syndrom. Helvet. med. Acta 13, 559 (1946).Google Scholar
  357. 357.
    Waaler, E.: Zit. nach Harter und Dickgiesser. Acta path, scand. (Copenh.) 17, 172 (1940).Google Scholar
  358. 358.
    Wagener, H. P.: Retinal lesions in acute disseminated lupus erythematosus. Med. Sci. 211, 240 (1946).Google Scholar
  359. 359.
    Walker, S. A., and E. P. Benditt: The serum proteins in diseases of connective tissue. An electrophoric study. J. Invest. Dermat. 14, 113 (1950).Google Scholar
  360. 360.
    Walsh, J. R., and H. J. Zimmerman: The demonstration of the “L. E.” phenomenon in patients with Penicin hypersensitivity. Blood 8, 65 (1953).PubMedGoogle Scholar
  361. 361.
    Watrin, J., B. Duperrat et J. Beurey: Le lupus érythémateux aigu. Etude anatomopathologique et hématologique. VIII. Congrès des Dermatologistes et Syphihgraphes de langue française, 1953, Rapports. G. Thomas, Nancy.Google Scholar
  362. 362.
    Watson, J. B., P. A. O’Leary and M. M. Hargraves: Neurophiles resembling L. E. cs in artificial bhsters. Arch, of Dermat. 63, 382 (1951).Google Scholar
  363. 363.
    White, C. J.: The problems of positive serologic test for syphüis in lupus erythematosus. Amer. J. Syph. 31, 235 (1947).Google Scholar
  364. 364.
    Wiener, A. S.: Auto-antibody formation and disease. Brit. Med. J. 1950 II, 163.CrossRefGoogle Scholar
  365. 365.
    Willis, R.: ustrations of cutaneous disease. London 1841; zit. nach Cohen u. Cabman.Google Scholar
  366. 366.
    Wilson, E.: Portraits of diseases of the skin, London 1847; zit. nach Cohen u. Cadman.Google Scholar
  367. 367.
    Wilson, A. P., and J. W. Jordan: Relationship of chronic discoid and disseminated lupus erythematosus. N. Y. State J. Med. 50, 2449 (1950).PubMedGoogle Scholar
  368. 368.
    Worken, B., and R. D. Pearson: Hematoxylin bodies associated with ergic angiitis in absence of lupus erathematosus. Arch, of Path. 56, 293 (1953).Google Scholar
  369. 369.
    Wuhrmann, F.: Humorale und culäre Blutveränderimgen bei den verschiedenen Endokarditisformen. Verh. dtsch. Ges. Kreislaufforsch. 20, 208 (1954).Google Scholar
  370. 370.
    335a. Wuhrmann, F.: Klinische Demonstrationen aus dem Gebiet der Kreislauf-Diagnostik und -Therapie. Praxis 39, 178 (1956).Google Scholar
  371. 371.
    335b. Zimmer, F. E., and M. M. Hargraves: The effect of blood coagulation on L. E. cell formation. Proc. Staff Meet. Mayo Clin. 27, 424 (1952).Google Scholar
  372. 372.
    Zollinger, H. U.: Die spontane und experimente Glomerulonephrose. Helvet. med. Acta 12, 23 (1945).Google Scholar
  373. 373.
    Zoutendyk, A., and J. Gear: Lupus erythematosus — an auto-antibody disease? Brit. Med. J. 1950 II, 1175CrossRefGoogle Scholar

Copyright information

© Springer-Verlag OHG. Berlin · Göttingen · Heidelberg 1956

Authors and Affiliations

  • W. Siegenthaler
  • R. Hegglin

There are no affiliations available

Personalised recommendations